References
- Kitchens DH. Xylitol in the prevention of oral diseases. Spec Care Dentist. 2005;25(3):140-4. https://doi.org/10.1111/j.1754-4505.2005.tb01424.x
- Wunder D, Bowen WH. Action of agents on glucosyltransferases from Streptococcus mutans in solution and adsorbed to experimental pellicle. Arch Oral Biol. 1999;44(3):203-14. https://doi.org/10.1016/S0003-9969(98)00129-0
- Svanberg M, Hietala EL, Knuuttila M. The effect of dietary xylitol on dentin formation in ovariectomized rats. Acta Odontol Scand. 1994;52(2):82-5. https://doi.org/10.3109/00016359409029059
- Svanberg M, Knuuttila M. The effect of dietary xylitol on recalcifying and newly formed cortical long bone in rats. Calcif Tissue Int. 1993;53(2):135-8. https://doi.org/10.1007/BF01321892
- Svanberg M, Knuuttila M. Dietary xylitol prevents ovariectomy induced changes of bone inorganic fraction in rats. Bone Miner. 1994;26(1):81-8. https://doi.org/10.1016/S0169-6009(08)80164-X
- Svanberg M, Knuuttila M. Dietary xylitol retards bone resorption in rats. Miner Electrolyte Metab. 1994;20(3):153-7.
- Svanberg M, Mattila P, Knuuttila M. Dietary xylitol retards the ovariectomy-induced increase of bone turnover in rats. Calcif Tissue Int. 1997;60(5):462-6. https://doi.org/10.1007/s002239900263
- Burgess TL, Qian Y, Kaufman S, Ring BD, Van G, Capparelli C, et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol. 1999;145(3):527-38. https://doi.org/10.1083/jcb.145.3.527
- Fuller K, Wong B, Fox S, Choi Y, Chambers TJ. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med. 1998;188(5):997-1001. https://doi.org/10.1084/jem.188.5.997
- Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999;397(6717):315-23. https://doi.org/10.1038/16852
- Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93(2):165-76. https://doi.org/10.1016/S0092-8674(00)81569-X
-
Jeong HJ, Tian Y, Kim BH, Nam MY, Lee HA, Yoo YJ, et al. Hypertonicity Down-regulates the
$1{\alpha}$ ,25(OH)2 Vitamin D3-induced Osteoclastogenesis Via the Modulation of RANKL Expression in Osteoblast. Int J Oral Biol. 2005;30(1):23-30. - Eriksen EF. Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord. 2010;11(4):219-27. https://doi.org/10.1007/s11154-010-9153-1
- Aubin JE. Advances in the osteoblast lineage. Biochem Cell Biol. 1998;76(6):899-910. https://doi.org/10.1139/o99-005
- Kim MJ, Jun YJ, Yu HI, Yang SY, Oh YM, Kim SH, et al. Altered Expression of RANKL/OPG after Alendronate Administration in the Developing Teeth of Postnatal Rats. Int J Oral Biol. 2011;36(1):37-42.
- Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N. Modulation of osteoclast differentiation by local factors. Bone. 1995;17(2 Suppl):87S-91S. https://doi.org/10.1016/8756-3282(95)00185-G
- Takahashi N, Udagawa N, Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun. 1999;256(3):449-55. https://doi.org/10.1006/bbrc.1999.0252
- Tsukii K, Shima N, Mochizuki S, Yamaguchi K, Kinosaki M, Yano K, et al. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha, 25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. Biochem Biophys Res Commun. 1998;246(2):337-41. https://doi.org/10.1006/bbrc.1998.8610
- Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, et al. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol. 1999;163(1):434-42.
- Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem. 1997;272(40):25190-4. https://doi.org/10.1074/jbc.272.40.25190
- Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, et al. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology. 2000;141(9):3478-84.
- Rani CS, MacDougall M. Dental cells express factors that regulate bone resorption. Mol Cell Biol Res Commun. 2000;3(3):145-52. https://doi.org/10.1006/mcbr.2000.0205
- Wise GE, Que BG, Huang H, Lumpkin SJ. Enhancement of gene expression in rat dental follicle cells by parathyroid hormone-related protein. Arch Oral Biol. 2000;45(10):903-9. https://doi.org/10.1016/S0003-9969(00)00053-4
- Kartsogiannis V, Zhou H, Horwood NJ, Thomas RJ, Hards DK, Quinn JM, et al. Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone. 1999;25(5):525-34. https://doi.org/10.1016/S8756-3282(99)00214-8
- Choi BK, Ohk SH, Lee HJ, Kang JH, Jeong GJ, Yoo YJ. Effects of whole cell sonicates of Treponema lecithinolyticum on osteoclast differentiation. J Periodontol. 2001;72(9):1172-7. https://doi.org/10.1902/jop.2000.72.9.1172
- Lee HA, Jeong H, Kim EY, Nam MY, Yoo YJ, Seo JT, et al. Bumetanide, the specific inhibitor of Na+-K+-2Cl- cotransport, inhibits 1alpha,25-dihydroxyvitamin D3-induced osteoclastogenesis in a mouse co-culture system. Exp Physiol. 2003;88(5):569-74. https://doi.org/10.1113/eph8802558